Science
Fimmic Launches Deep Learning AI Analytics on Their Next-Generation...
- Anatomic Pathology
- Clinical Laboratories
- Cloud Computing
- Conferences
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- Image Analysis
- Informatics
- International
- Laboratory Informatics
- Laboratory Management & Operations
- Medical Research
- Pathology News
- Science
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
Helsinki, Finland, 1st March, 2017 - Fimmic, a company developing intelligent, cloud-based software solutions for digital microscopy announces the launch of their next-generation WebMicroscope Deep Learning Platform at USCAP 2017 in March 6-8....
Trevor Heritage Joins Inspirata as Senior Vice President of Cancer ...
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Cloud Computing
- Data Management
- Device Manufacturers
- Digital Pathology News
- File format
- Genetics
- Image Analysis
- Informatics
- Laboratory Informatics
- Medical Research
- Molecular Pathology
- Pathology News
- Science
- TeleHealth
- Tissue banking
- Vendor products
- Web/Tech
- Whole slide
Dr. Heritage is widely recognized for his work in the development of informatics systems for drug and performance chemical discovery, translational and personalized medicine, and pharmaceutical product development. San Francisco, CA, February...
Will Not Using Image Analysis in Pathology be Perceived as Irrespon...
- Advocacy
- Anatomic Pathology
- Blogs
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- General Healthcare News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Medical Research
- Molecular Pathology
- Pathology News
- Science
- TeleHealth
- Web/Tech
- Whole slide
Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com. It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More...
Courtesy of Clinical OMICs - Molecular Diagnostics in Personalized Medicine Johns Hopkins researchers have published new data that suggests epigenetic changes controlling how DNA operates, provides survival advantages to a subset of...
Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...
In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...
